Kathy Liu

机构：University of Calgary, Cerus (United States) · ORCID：0000-0002-1531-3443

发表论文 28 篇 · 总被引 624 次 · h-index 7

代表论文

• Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation (2020 · Journal of Hepatology · 被引 230)
• Converting Adult Pancreatic Islet α Cells into β Cells by Targeting Both Dnmt1 and Arx (2017 · Cell Metabolism · 被引 216)
• Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension (2019 · Journal of Glaucoma · 被引 52)
• Baseline Time to Stabilization Identifies Anterior Cruciate Ligament Rupture Risk in Collegiate Athletes (2016 · The American Journal of Sports Medicine · 被引 37)
• Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases (2023 · BioDrugs · 被引 21)
• Time to surgical management of distal radius fractures: effects on health care utilization and functional outcomes (2024 · Canadian Journal of Surgery · 被引 6)